论文部分内容阅读
黄又彭,早年毕业于瑞士日内瓦大学医学院,获免疫学博士学位,现为解放军305医院抗衰老临床中心顾问,瑞士联邦医学科学院临床免疫学学会会员,欧洲共同体免疫学会会员,北京国际抗衰老医学中心主任。在美国,对60岁以上的肿瘤患者,不提倡做放化疗,因为放化疗一般只会缩短病人的生存期。如果在70岁以前长肿瘤,这是病理性的。70岁以后生长的肿瘤就是生理性肿瘤,没有什么病理意义。黄教授曾在某电视台的新闻报道中,看
Huang and Peng, graduated from Geneva University School of Medicine in Switzerland with a Ph.D. degree in immunology. He is currently a consultant of the Anti-Aging Clinical Center of the 305th Hospital of PLA, a member of the Clinical Immunology Institute of the Swiss Federal Institute of Medical Sciences, a member of the European Community Immunization Association, Medical Center Director. In the United States, chemoradiotherapy is not recommended for cancer patients over the age of 60 because radiotherapy and chemotherapy generally shorten the patient’s survival. If you have a long tumor before the age of 70, this is pathological. After 70 years of growth of the tumor is a physiological tumor, there is no pathological significance. Professor Huang once saw the news report of a television station